More stories
Quarterly Psychedelics Briefing: Q3 2026
Welcome to our Q3 2026 Quarterly Briefing. Every three months, our Founder & Editor Josh Hardman walks you through major developments from the prior...
Weekly Psychedelic Policy Briefing, September 21, 2026
The FDA heard 80 speakers on the future of psychedelic drugs, and its federal panel asked none of them a question. The American Legion...
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Optimi Health has Health Canada authorization for a Phase 2 trial of natural psilocybin in up to 200 adults with major depressive disorder. Dosing...
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5...
Now that federal lobbying data from the second quarter of the year is available to retrieve, we present our regular update on the state...
Introducing The Psychedelic News Feed Podcast
Post Content
Field Notes #5: ‘Psychedelics Week’ in Washington D.C.
Welcome to our fifth Field Note. As a reminder, Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that...
What Lynn Watkins Actually Told the FDA about Chronic Pain and Psychedelics
Reuters attributed a quote about access and reimbursement to Lynn Watkins at Monday's FDA hearing on psychedelic drugs. She didn't say it. What she...
Beyond the Foxhole: How Psychedelic Policy’s Coalition Is Growing Past Veterans
Veterans built the psychedelic policy movement in state legislatures. This year, firefighters, police officers, and EMTs joined them, and states once written off as...
‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop
On Tuesday, the Advanced Research Projects Agency for Health (ARPA-H) held a day-long gathering related to its ibogaine funding opportunity, dubbed Accelerating Safe Clinical...
Pα+ Psychedelic Bulletin #231: Compass Shares 52 Week Follow-Up, Training Grant Recipients; Xylo Enters...
Earlier this month, Compass Pathways shared topline data from Part C of its smaller, placebo-controlled Phase 3 trial, COMP005. As a reminder, COMP005 enrolled...
Most popular
How to Get DMT: Obtaining the Spirit Molecule
DMT, or N,N-dimethyltryptamine, is known to be one of the world’s most powerful psychedelics. It is capable of producing experiences with intensity and profundity...
Having Sex on DMT: What You Need to Know
For those of you who have dived into the wonders of DMT, you may be investigating this article to see how sex on DMT...
DMT Pricing Guide
Smoking or vaping DMT can be a life-changing experience. The hallucinogenic compound is gaining more popularity in the world of mainstream psychedelics. But without...
William Leonard Pickard participating in celebration for Sasha Shulgin’s new book ‘The Nature of...
A Celebration of the Pioneering Legacy of Sasha and Ann Shulgin
Saturday June 26 and Sunday June 27, 2021
This is a virtual symposium which will...
PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians
In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle once again meet through the airwaves to discuss recent news articles and see where that...
